News | Lung Imaging | May 21, 2018

Association warns that provider ignorance of low-dose CT screening guidelines, lack of physician and patient education, and low Medicare reimbursement result in increased mortality

ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines

May 21, 2018 — A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer screening guidelines may be resulting in thousands of unnecessary deaths each year. The statement attributes the phenomenon to physician ignorance of lung cancer screening guidelines, lack of patient and physician education on the benefits of screening, and drastically low Medicare reimbursement for low-dose computed tomography (LDCT) lung cancer screening exams.

More than 220,000 people will be diagnosed with lung cancer in 2018. Nearly 160,000 people will die from the disease — more than from breast, colon and prostate cancers combined. This exam is the first and only cost-effective test proven to significantly reduce lung cancer deaths, according to the ACR.

The United States Preventive Services Task Force (USPSTF) recommends lung cancer screening for high-risk, older current and former smokers. Yet, these exams remain comparatively unused – according to a recent study presented at the American Society of Clinical Oncology (ASCO).

“CT lung cancer screening can save more lives than any cancer screening test in history, but patients are not hearing about this test from their doctors. Medicare is not adequately covering these exams. This noncompliance and practical non-coverage is contributing to unnecessary deaths due to lack of screening,” said Ella Kazerooni, M.D., FACR, chair of the ACR Lung Cancer Screening Committee and ACR Thoracic Imaging Panel.

Updates to Lung-RADS — a quality assurance tool to standardize lung cancer screening CT reporting and management recommendations — has reduced false positive rates by 75 percent compared to previous studies, according to the college. This process will improve, but only with an adequate number of patients to screen and review.

Previous psychological studies show that patient concern over cancer screening false positives is short-term with no lasting effects.

Given the immediate threat to older current and former smokers from this disease, the significant lifesaving benefit of these exams outweighs any likely harms to the defined screening population, the association said. In fact, patients are required by law to be made aware of the harms of screening and other pertinent information prior to any exams being performed.

Unlike breast and colon cancer screening, a patient’s primary care physician must approve the patient to get a lung cancer screening exam during a shared-decision making visit. Many of these providers are unaware of the exams – or not informed on the benefits of these scans.

According to the ASCO study, 12,000 people per year may be dying due to lack of screening. Many of these people may never hear that there is a test that can help save them. Additional education of both ordering physicians and patients, such as “Saved by the Scan,” is necessary.

Shortly after providing coverage for these exams, the Centers for Medicare & Medicaid Services slashed Medicare reimbursement to approximately $60 per exam. That is less than half the Medicare provider reimbursement for a mammogram. Such cuts have largely restricted the number of facilities financially able to provide these scans to large teaching hospitals. The ACR said funding for lung cancer screening exams needs to be greatly increased.

The medical community is working to maximize the lifesaving benefits of these tests, by reducing false positive exams and restricting screening to populations most likely to benefit from screening. However, the ACR said Medicare needs to provide realistic coverage for these tests. These processes can occur at the same time.

“Thousands of people each year should not be allowed to die needlessly while the medical community fine tunes the only exam proven to save lives from the nation’s leading cancer killer. Medicare must also provide adequate reimbursement. We need to save lives now,” said Kazerooni.

For more information: www.radiologyinfo.org


Related Content

News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Radiation Therapy

July 3, 2024 — Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support ...

Time July 03, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — Thirona, a Netherlands-based global company providing high-precision advanced lung image analysis with ...

Time June 27, 2024
arrow
Subscribe Now